Related Experiment Video
Updated: Aug 11, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart
Jack F Price1, Jeffrey A Towbin, William J Dreyer
1Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Baylor College of Medicine; Texas Children's Hospital, 6621 Fannin, MC 19345-C, Houston, TX 77030, USA.
Insights
Outpatient parenteral inotropic therapy (PIT) can reduce hospitalizations and emergency visits for children with advanced heart failure. This therapy may successfully bridge selected pediatric patients to cardiac transplantation.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Medical Therapy
Background:
- Advanced heart failure in children presents significant morbidity and mortality.
- Standard medical therapies are often ineffective for pediatric advanced chronic heart failure.
Purpose of the Study:
- To review the institutional experience with outpatient parenteral inotropic therapy (PIT).
- To evaluate the efficacy of PIT for advanced chronic heart failure in pediatric patients.
Main Methods:
- Retrospective review of medical records for pediatric patients treated with outpatient PIT.
- Analysis of patient demographics, duration of therapy, emergency department visits, hospital admissions, and ejection fraction (EF%).
Main Results:
- Seven pediatric patients received outpatient PIT (mean age 14.6 years).
- PIT significantly reduced emergency department visits and hospital admissions for heart failure exacerbations.
- Mean EF% improved in patients with systolic dysfunction on PIT.
- Six out of seven patients were successfully bridged to cardiac transplantation.
Conclusions:
- Outpatient continuous parenteral inotropic therapy (PIT) is a viable treatment option for selected pediatric patients.
- PIT can serve as a successful bridge to cardiac transplantation in pediatric heart failure management.
Background:
Advanced heart failure in children is associated with high morbidity and mortality and is often refractory to standard medical therapy. The purpose of this study was to review our institutional experience with the use of outpatient parenteral inotropic therapy (PIT) for advanced chronic heart failure in children.
Methods And Results:
We reviewed the medical records of all patients treated with PIT as outpatients. Seven patients received outpatient PIT from 2/99 to 1/05 (mean age was 14.6 years +/- 3.7). Median duration of therapy was 10 weeks (range 4-84 weeks). The mean number of emergency department visits per patient was greater before starting PIT than after starting PIT (2.3 +/- 1.8 versus 1.1 +/- 2.2, P < .05). The mean number of hospital admissions from exacerbation of heart failure symptoms decreased after starting PIT (2.1 +/- 1.3 versus 0.6 +/- 0.8, P < .05). Mean EF% in patients with systolic dysfunction improved while on therapy (30 +/- 14% before versus 39 +/- 16% after, P < .05). There was 1 death and 5 complications in 2 patients. Six patients were successfully bridged to transplantation.
Conclusion:
Outpatient continuous parenteral inotropic therapy may serve as a successful bridge to cardiac transplantation in selected pediatric outpatients.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction

